Growth hormone use in pediatric growth hormone deficiency and other pediatric growth disorders

Ronald (Ron) Rosenfeld, D. B. Allen, M. H. MacGillivray, C. Alter, P. Saenger, H. Anhalt, R. Hintz, H. P. Katz

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The diagnosis and management of growth disorders in children, particularly disorders that respond to therapy with growth hormone (GH), raise challeging clinical and economic issues. Several such issues are presented in the following article in which Dr. Ron Rosenfeld examines the evaluation and diagnosis of the child with short stature; Dr. David B. Allen discusses the anabolic and metabolic indications for GH treatment in children; Dr. Margaret H. MacGillivray reviews GH dosing, height outcomes, and follow up; and Dr. Craig Alter presents the payer's perspective on the diagnosis and treatment of pediatric GH deficiency. In addressing the use of GH in other pediatric populations, Dr. Paul Saenger focuses on Turner syndrome, Dr. Henry Anhalt on chronic renal insufficiency of childhood, and Dr. Ray Hintz on idiopathic short stature. Dr. Harvey P. Katz presents one managed care organization's policy and implementation plan that is used to guide decisions regarding coverage for GH treatment.

Original languageEnglish (US)
JournalAmerican Journal of Managed Care
Volume6
Issue number15 SUPPL.
StatePublished - 2000
Externally publishedYes

Fingerprint

Growth Disorders
Growth Hormone
Pediatrics
Turner Syndrome
Managed Care Programs
Therapeutics
Chronic Renal Insufficiency
managed care
Economics
indication
Organizations
coverage
childhood
Population
evaluation

ASJC Scopus subject areas

  • Medicine(all)
  • Nursing(all)
  • Health(social science)
  • Health Professions(all)

Cite this

Rosenfeld, R. R., Allen, D. B., MacGillivray, M. H., Alter, C., Saenger, P., Anhalt, H., ... Katz, H. P. (2000). Growth hormone use in pediatric growth hormone deficiency and other pediatric growth disorders. American Journal of Managed Care, 6(15 SUPPL.).

Growth hormone use in pediatric growth hormone deficiency and other pediatric growth disorders. / Rosenfeld, Ronald (Ron); Allen, D. B.; MacGillivray, M. H.; Alter, C.; Saenger, P.; Anhalt, H.; Hintz, R.; Katz, H. P.

In: American Journal of Managed Care, Vol. 6, No. 15 SUPPL., 2000.

Research output: Contribution to journalArticle

Rosenfeld, RR, Allen, DB, MacGillivray, MH, Alter, C, Saenger, P, Anhalt, H, Hintz, R & Katz, HP 2000, 'Growth hormone use in pediatric growth hormone deficiency and other pediatric growth disorders', American Journal of Managed Care, vol. 6, no. 15 SUPPL..
Rosenfeld RR, Allen DB, MacGillivray MH, Alter C, Saenger P, Anhalt H et al. Growth hormone use in pediatric growth hormone deficiency and other pediatric growth disorders. American Journal of Managed Care. 2000;6(15 SUPPL.).
Rosenfeld, Ronald (Ron) ; Allen, D. B. ; MacGillivray, M. H. ; Alter, C. ; Saenger, P. ; Anhalt, H. ; Hintz, R. ; Katz, H. P. / Growth hormone use in pediatric growth hormone deficiency and other pediatric growth disorders. In: American Journal of Managed Care. 2000 ; Vol. 6, No. 15 SUPPL.
@article{263049abb0bf40149f40769e2f6512df,
title = "Growth hormone use in pediatric growth hormone deficiency and other pediatric growth disorders",
abstract = "The diagnosis and management of growth disorders in children, particularly disorders that respond to therapy with growth hormone (GH), raise challeging clinical and economic issues. Several such issues are presented in the following article in which Dr. Ron Rosenfeld examines the evaluation and diagnosis of the child with short stature; Dr. David B. Allen discusses the anabolic and metabolic indications for GH treatment in children; Dr. Margaret H. MacGillivray reviews GH dosing, height outcomes, and follow up; and Dr. Craig Alter presents the payer's perspective on the diagnosis and treatment of pediatric GH deficiency. In addressing the use of GH in other pediatric populations, Dr. Paul Saenger focuses on Turner syndrome, Dr. Henry Anhalt on chronic renal insufficiency of childhood, and Dr. Ray Hintz on idiopathic short stature. Dr. Harvey P. Katz presents one managed care organization's policy and implementation plan that is used to guide decisions regarding coverage for GH treatment.",
author = "Rosenfeld, {Ronald (Ron)} and Allen, {D. B.} and MacGillivray, {M. H.} and C. Alter and P. Saenger and H. Anhalt and R. Hintz and Katz, {H. P.}",
year = "2000",
language = "English (US)",
volume = "6",
journal = "American Journal of Managed Care",
issn = "1088-0224",
publisher = "Ascend Media",
number = "15 SUPPL.",

}

TY - JOUR

T1 - Growth hormone use in pediatric growth hormone deficiency and other pediatric growth disorders

AU - Rosenfeld, Ronald (Ron)

AU - Allen, D. B.

AU - MacGillivray, M. H.

AU - Alter, C.

AU - Saenger, P.

AU - Anhalt, H.

AU - Hintz, R.

AU - Katz, H. P.

PY - 2000

Y1 - 2000

N2 - The diagnosis and management of growth disorders in children, particularly disorders that respond to therapy with growth hormone (GH), raise challeging clinical and economic issues. Several such issues are presented in the following article in which Dr. Ron Rosenfeld examines the evaluation and diagnosis of the child with short stature; Dr. David B. Allen discusses the anabolic and metabolic indications for GH treatment in children; Dr. Margaret H. MacGillivray reviews GH dosing, height outcomes, and follow up; and Dr. Craig Alter presents the payer's perspective on the diagnosis and treatment of pediatric GH deficiency. In addressing the use of GH in other pediatric populations, Dr. Paul Saenger focuses on Turner syndrome, Dr. Henry Anhalt on chronic renal insufficiency of childhood, and Dr. Ray Hintz on idiopathic short stature. Dr. Harvey P. Katz presents one managed care organization's policy and implementation plan that is used to guide decisions regarding coverage for GH treatment.

AB - The diagnosis and management of growth disorders in children, particularly disorders that respond to therapy with growth hormone (GH), raise challeging clinical and economic issues. Several such issues are presented in the following article in which Dr. Ron Rosenfeld examines the evaluation and diagnosis of the child with short stature; Dr. David B. Allen discusses the anabolic and metabolic indications for GH treatment in children; Dr. Margaret H. MacGillivray reviews GH dosing, height outcomes, and follow up; and Dr. Craig Alter presents the payer's perspective on the diagnosis and treatment of pediatric GH deficiency. In addressing the use of GH in other pediatric populations, Dr. Paul Saenger focuses on Turner syndrome, Dr. Henry Anhalt on chronic renal insufficiency of childhood, and Dr. Ray Hintz on idiopathic short stature. Dr. Harvey P. Katz presents one managed care organization's policy and implementation plan that is used to guide decisions regarding coverage for GH treatment.

UR - http://www.scopus.com/inward/record.url?scp=0033819537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033819537&partnerID=8YFLogxK

M3 - Article

VL - 6

JO - American Journal of Managed Care

JF - American Journal of Managed Care

SN - 1088-0224

IS - 15 SUPPL.

ER -